We selectively seek strategic alliances that enable us to maintain financial and operational flexibility while retaining significant clinical development, and operational involvement and the commercial rights to our drug candidates. We very much believe in the value of such partnerships, but importantly, with the right deal architecture that preserves for Cytokinetics key rights and participation. We are currently engaged in a major partnership with Amgen in the area of cardiac contractility for the potential treatment of heart failure. In addition, we actively seek strategic alliances for our unpartnered programs in pre-clinical and clinical development as well as academic collaborations with leading investigators in related fields.

            Amgen Details


Astellas Details